Skip to content

Application of Ultra-high Frequency Ultrasonography (UHFUS) to the Study of Gingival Tissues

Ulta-High Frequency Ultrasound Assessment of Normal Versus Gingivitis Affected Gingival Tissues

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06480825
Enrollment
40
Registered
2024-06-28
Start date
2024-04-02
Completion date
2028-07-01
Last updated
2026-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingivitis, Periodontitis

Brief summary

Gingival inflammation triggered by the accumulation of bacterial is the primary risk factor for the development of periodontitis. Clinically, localized signs of inflammation limited to the gingiva, presence of significant bacterial plaque load, and stable attachment levels on the periodontium can be observed in course of gingivitis. The aim of the present study is to compare clinical aspects of gingival tissue in healthy patients versus patients with gingivitis to assess the ultrastructural variations present in course of inflammation. Patients with gingivitis and healthy controls will be enrolled. All patients will undergo ultra-high frequency ultrasonographic scans (70 MHz) of gingival tissue on three areas per dental arch (anterior, middle right, middle left). Gingival thickness, echogenicity, and vascularization assessed through resisitive index will be evaluated.

Interventions

OTHERPerformance of ultrasonographic scan

Ultra-high frequency ultrasonographic scan of gingival tissues

Sponsors

University of Pisa
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* males or females of age \> 18 years * presence of at least 20 teeth * full-mouth plaque score (FMPS) \>50% * FMBS \>30% * ability and willingness to give informed consent

Exclusion criteria

* pregnancy or breastfeeding * pharmacological treatment with antinflammatory drugs, statins, or either local or systemic antibiotics (within the previous 30 days) * smoking habit * dental or periodontal condition requiring immediate treatment * refusal to be enrolled in the study

Design outcomes

Primary

MeasureTime frameDescription
Echogenicitymeasured once at enrollemntVariations in echogenicity assessed through grey levels distribution between healthy patients versus gingivitis

Secondary

MeasureTime frameDescription
Vascular parametersmeasured once at enrollemntVariations in vascularization assessed through grey levels distribution between healthy patients versus gingivitis
DMFTmeasured once at enrollementThe Decayed-Missing-Filled Teeth (DMFT) index, categorized as Low (0-4), Moderate (5-13), and High (14+), will evaluate overall dental health.
PPDmeasured once at enrollementProbing Pocket Depth (PPD) will be measured using a UNC-15 periodontal probe with 0.3 N pressure, recording six sites per tooth (distobuccal, buccal, mesiobuccal, distolingual, lingual, mesiolingual), rounded to the nearest millimeter.
FMBSmeasured once at enrollementFull Mouth Bleeding Score (FMBS) will be determined dichotomously post-probing.
FMPSmeasured once at enrollementFull Mouth Plaque Score (FMPS) will assess plaque presence on each tooth surface, with scores of 1 for presence and 0 for absence across six sites per tooth.

Countries

Italy

Contacts

CONTACTRossana Izzetti
rossana.izzetti@unipi.it3475205619

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026